Escalon Medical (NASDAQ:ESMC) is climbing higher in pre-market trading after the company said it received U.S. Food and Drug Administration…
Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares were down about 5% in pre-market trade on Friday after it priced an underwritten public offering…
Intercept Pharmaceuticals (NASDAQ:ICPT) shares edged higher in Friday’s pre-market session, after the clinical-stage biopharmaceutical company late Thursday said its public…
Convenience-story chain operator the Pantry (NASDAQ:PTRY) named Thomas W. “Tad” Dickson, the former CEO of Harris Teeter Supermarkets, as its…
Ahead of the US March jobs report at 8:30AM ET, the street is currently modeling up 200,000 (versus 175,000 in…
At the conclusion of last Thursday’s FDA meeting of the Molecular and Clinical Genetics Advisory Panel, the panel members voted…
Fourth-quarter (January) adjusted EPS of $0.83, 38% same-week growth, were equal to consensus, and within management’s $0.82-$0.85 guidance. A revenue…
After the markets closed on Wednesday, March 26, Paychex (NASDAQ:PAYX) reported better-than-expected fiscal third-quarter results. Revenue growth was better than…
Emerge Energy Services LP (NYSE:EMES) has been upgraded by analysts at Robert W. Baird to an outperform rating from neutral. The…
Catalyst Pharmaceutical Partners (CPRX) shares were higher over 7% in recent pre-market trade after pricing a public offer of 11.33…
Before the markets opened Monday, Biogen Idec announced the FDA has extended its regulatory review for Plegridy by three months.…
For the first time as a public company, Inogen reported fourth-quarter results after the close on Thursday, March 27. Revenue…